Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Infect Dis ; 200(11): 1658-61, 2009 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-19848610

RESUMO

In the context of a trial studying intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Lambaréné, Gabon, children aged 18-30 months were followed up after having received their last dose at an age of 15 months. In the intention-to-treat population, the protective efficacy against all malaria episodes was -18.0 (95% confidence interval, -97.4 to 29.5; P = .529). The protective efficacy against first or only anemia episode was -45.3 (95% confidence interval, -234.5 to 36.3; P=.375). The protective efficacies were negative and were not statistically significant. These results do not appear to support the concept of a rebound effect after intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants. Clinical trials registration. NCT00167843.


Assuntos
Antimaláricos/uso terapêutico , Malária/prevenção & controle , Pirimetamina/uso terapêutico , Sulfadoxina/uso terapêutico , Anemia/epidemiologia , Anemia/prevenção & controle , Pré-Escolar , Estudos de Coortes , Método Duplo-Cego , Esquema de Medicação , Combinação de Medicamentos , Gabão/epidemiologia , Humanos , Lactente , Estimativa de Kaplan-Meier , Malária/tratamento farmacológico , Malária/epidemiologia , Morbidade
2.
Malar J ; 7: 60, 2008 Apr 18.
Artigo em Inglês | MEDLINE | ID: mdl-18423025

RESUMO

BACKGROUND: Insecticide-treated bed nets (ITNs) range among the most effective measures of malaria prophylaxis, yet their implementation level in sub-Saharan Africa is still low. The goal of this study was to investigate the influence of socio-economic factors on the use of bed nets by mothers in Gabon. METHODS: A cross-sectional study was conducted completing pre-tested, interviewer-administered questionnaires exploring socioeconomic proxy measures with 397 mothers or guardians of young children. Respondents were grouped according to their socio-economic situation, using scores. The condition of the bed nets was evaluated during a home visit. RESULTS: Socio-economic factors of wellbeing were negatively associated with bed net use, such as living in a stone house (OR 0.26, 95% CI 0.14-0.48), running water in the house (OR 0.44, 95% CI 0.21-0.92), shower/flush toilet in the house (OR 0.39/0.34, 95% CI 0.21-0.75/0.16-0.73), ownership of a freezer (OR 0.50, 95% CI 0.26-0.96) and belonging to the highest group in the economic score (OR 0.32, 95% CI 0.15-0.67). In contrast, similar factors were positively associated with a good maintenance condition of the bed nets: higher monthly income (OR 5.64, 95% CI 2.41-13.19) and belonging to the highest group in the economic score (OR 2.55, 95% CI 1.19 - 5.45). CONCLUSION: Among the poorest families in Lambaréné the coverage with untreated nets (UTNs) is the highest, but the condition of these UTNs is the worst. To achieve a broad implementation of ITNs in Lambaréné, there is an urgent need for educational programmes as well as need-tailored marketing strategies for ITNs.


Assuntos
Malária/epidemiologia , Malária/prevenção & controle , Controle de Mosquitos/métodos , Pré-Escolar , Estudos Transversais , Feminino , Gabão/epidemiologia , Humanos , Lactente , Tutores Legais , Mães , Fatores Socioeconômicos , Inquéritos e Questionários
3.
J Infect Dis ; 196(11): 1595-602, 2007 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-18008242

RESUMO

BACKGROUND: Intermittent preventive treatment aims to maximize the protective effects of malaria chemoprophylaxis while minimizing the deleterious effects. METHODS: In Gabon, 1189 infants received either sulfadoxine-pyrimethamine (SP; 250 and 12.5 mg, respectively) or placebo at 3, 9, and 15 months of age. Children were actively followed-up until 18 months of age. RESULTS: In the intention-to-treat population at 18 months of follow-up, 84 children (17%) in the SP group had > or =1 episode of anemia, versus 108 (21%) in the placebo group (protective efficacy, 22% [95% confidence interval {CI}, -1% to 40%]; P=.06). In the intervention group, there were 66 episodes during 485 person-years at risk, compared with 79 episodes during 497 years in the placebo group (protective efficacy, 17% [95% CI, -24% to 45%; P=.36). The effects were similar at 12 months of follow-up. The study drug was safe and well tolerated. CONCLUSIONS: The intervention was efficacious, producing a reduction in risk for anemia but a smaller effect against malaria. It is a valuable additional tool to control malaria in a highly vulnerable age group. Remaining important questions are currently being addressed in further studies. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00167843.


Assuntos
Antimaláricos/administração & dosagem , Malária Falciparum/prevenção & controle , Parasitemia/prevenção & controle , Pirimetamina/administração & dosagem , Sulfadoxina/administração & dosagem , Anemia/induzido quimicamente , Anemia/epidemiologia , Antimaláricos/efeitos adversos , Método Duplo-Cego , Esquema de Medicação , Combinação de Medicamentos , Feminino , Gabão/epidemiologia , Hematócrito , Hemoglobinas/metabolismo , Humanos , Incidência , Lactente , Estimativa de Kaplan-Meier , Malária Falciparum/sangue , Malária Falciparum/epidemiologia , Masculino , Parasitemia/sangue , Parasitemia/epidemiologia , Parasitemia/parasitologia , Seleção de Pacientes , Pirimetamina/efeitos adversos , Projetos de Pesquisa , Sulfadoxina/efeitos adversos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...